This inventor holds 3 USPTO granted patents. Top assignees: Bristol-Myers Company, Other. Active years: 1976-1991.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Liverpool, NY (US) (1976 - 1979)
- Elbridge, NY (US) (1991)
Company Filing History:
2 out of 637 
1 out of 834,570 Years Active: 1976-1991
Title: Thomas Andrew Jenks: Innovator in Blood Platelet Antiaggregative Agents
Introduction
Thomas Andrew Jenks, an inventive mind from Liverpool, NY, has made significant contributions to the field of pharmaceuticals with his groundbreaking patents. With a total of two patents to his name, his research focuses primarily on compounds that serve critical functions in medical applications, particularly as blood platelet antiaggregative and antihypertensive agents.
Latest Patents
Jenks's latest patents include the innovative Alkyl 5,6-dichloro-3,4-dihydro-2(1H)-iminoquinazoline-3-acetate, which is recognized for its effectiveness as a blood platelet antiaggregative agent. This invention describes an improved process for preparing 6,7-dichloro-1,5-dihydroimidazo[2,1-b]quinazolin-2(3H)-one in high yield through a novel intermediate formulation. Furthermore, he has developed a new process for synthesizing optionally substituted 1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones, emphasizing the adaptability for preparing 5,6-disubstituted variants, such as 5,6-dimethyl-1,2,3,5-tetrahydroimidazo-[2,1-b]quinazolin-2-one.
Career Highlights
Jenks is affiliated with Bristol-Myers Squibb Company, where he leverages his expertise to drive forward the research and development of vital pharmaceutical compounds. His innovative work emphasizes the synthesis and application of key chemical compounds that are beneficial in medical treatments, thereby contributing to advancements in healthcare.
Collaborations
During his career, Jenks has collaborated with esteemed coworkers such as Warren Neil Beverung, Jr. and Richard A. Partyka. These partnerships in research and development underscore the importance of teamwork in achieving breakthroughs in pharmaceutical sciences.
Conclusion
Thomas Andrew Jenks stands out as a notable inventor whose patents have the potential to make significant impacts in the medical field. His innovative processes for synthesizing vital compounds demonstrate his commitment to improving treatments for various health conditions. Through his work and collaborations, he continues to contribute to the advancement of pharmaceutical sciences.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile